Saudi Pharmaceutical Industries and Medical Appliances Corporation (SASE:2070) agreed to acquire 68% stake in Osmopharm SA for SAR 16.1 million on November 14, 2023. The transaction s expected to be completed in the first half of 2024, contingent on regulatory approvals. Olha Demianiuk and Dr. Alexander Wyss of Baker & McKenzie acted as legal advisor to Saudi Pharmaceutical Industries and Medical Appliances Corporation.
Saudi Pharmaceutical Industries and Medical Appliances Corporation
Equities
2070
SA0007879188
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
34.15 SAR | -0.87% | -8.82% | -9.79% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.79% | 1.1B | |
+37.74% | 723B | |
+34.64% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.19% | 244B | |
+10.03% | 208B | |
-3.97% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- 2070 Stock
- News Saudi Pharmaceutical Industries and Medical Appliances Corporation
- Saudi Pharmaceutical Industries and Medical Appliances Corporation agreed to acquire 68% stake in Osmopharm SA for SAR 16.1million.